SynthesisJournal of robotic surgery2026
Single-port versus multi-port robotic-assisted partial nephrectomy in perioperative, oncological, and renal function outcomes: a systematic review and meta-analysis.
Synthesis in Journal of robotic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Development and validation of objective performance metrics for robot-assisted basic surgical skills in a simulated anastomosis task using a single-port robotic system.Journal of robotic surgery · 2026Article
- Robotic partial nephrectomy is inching toward the gold standard for small renal masses-a narrative review.Translational andrology and urology · 2026Review
- Single‑port versus multi‑port robotic-assisted partial nephrectomy: a systematic review and meta-analysis of propensity score-matched cohort studies.International urology and nephrology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
As a novel surgical method for partial nephrectomy (PN), single-port robot-assisted partial nephrectomy (SP-RAPN) is becoming widely used. The efficacy and safety outcomes comparison between SP-RAPN and traditional multi-port RAPN (MP-RAPN) is still unclear. Hence, this study aims to compare the perioperative, oncological, and renal function outcomes between SP-RAPN and MP-RAPN based on updated evidence. A literature search was performed online in Web of Science, PubMed, Embase, Cochrane Library, and ClinicalTrials.gov, and eligible studies were selected based on the criteria. The quality assessment of the included studies was performed by using the revised Cochrane Collaboration Risk of Bias Tool for randomized-controlled studies and the Newcastle-Ottawa Quality Assessment Scale for cohort studies. Effect sizes were calculated as odds ratios (ORs) for binary outcomes and as standard mean differences (SMDs) for continuous outcomes. All statistical analyses were conducted using Review Manager (version 5.4). 16 studies involving 2426 patients were finally analyzed. Compared to MP-RAPN, SP-RAPN shows lower off-clamp rate (OCR) (OR = 2.36, 95% confidence interval [CI]: 1.09, 5.12), less estimated blood loss (EBL) (SMD = -0.22, 95% CI: -0.38, -0.06), reduced length of hospital stay (SMD = -0.58, 95% CI: -0.91, -0.25), higher same-day discharge rate (OR = 3.62, 95% CI: 1.85, 7.09), lower positive surgical margin (OR = 0.67, 95% CI: 0.47, 0.96), and lower postoperative creatinine (SMD = -0.53, 95% CI: -0.86, -0.20). In addition, SP-RAPN has longer warm ischemia time (WIT) (SMD = 0.31, 95% CI: 0.07, 0.55) and less trifecta achievement (OR = 0.56, 95% CI: 0.34–0.97). No significant differences were found between operation time (OT), perioperative complications rate, intraoperative transfusion, intraoperative conversion, readmission after discharge, pain score, perioperative morphine milligram equivalent use, tumor recurrence rate, and other renal function outcomes. Large heterogeneity was found in OT, OCR, WIT, and EBL. As an alternative to MP-RAPN, SP-RAPN presents acceptable efficacy and safety. However, its influence on WIT, trifecta achievement, and renal function needs cautious assessment. More well-designed, prospective RCTs are vital to reinforce our findings.
Indexed as
Identifiers
41925796What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.